Sera Prognostics Insider Trades
NASDAQ: SERAHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 22 · $230.05K
- Shares bought / sold
- 0 / 115.08K
- Net activity
- Net selling $230,049
Sera Prognostics insider activity
Over the last 12 months, Sera Prognostics insiders reported 44 transactions on SEC Form 4: 0 open-market purchases and 22 sales. Insiders bought $0 and sold $230,049 worth of stock, for net insider selling of $230,049. The largest seller was Lindgardt Zhenya, with $160,621 in reported sales.
The most recent filing shows Lindgardt Zhenya (Chief Executive Officer) selling 7,022 shares at $2.00 on Sep 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SERA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SERA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 10, 2026 | Inglis Tiffany Eul DavisChief Medical Officer | Sale | 486 | $972 | Form 4 |
| Sep 10, 2026 | Anderson Dyaarl Lee Jr.Chief Commercial Officer | Sale | 1,800 | $3.60K | Form 4 |
| Sep 10, 2026 | Jackson BenjaminGeneral Counsel | Sale | 2,190 | $4.38K | Form 4 |
| Sep 10, 2026 | Lindgardt ZhenyaChief Executive Officer | Sale | 7,022 | $14.04K | Form 4 |
| Sep 8, 2026 | Lindgardt ZhenyaChief Executive Officer | Sale | 20,139 | $40.28K | Form 4 |
| Aug 31, 2026 | Gleason ScottChief Financial Officer | Award | 117,924 | — | Form 4 |
| Jul 10, 2026 | CRITCHFIELD GREGORY CDirector | Award | 1,594 | — | Form 4 |
| Jul 10, 2026 | CRITCHFIELD GREGORY CDirector | Award | 22,426 | — | Form 4 |
| Jul 10, 2026 | Barlow Jane FDirector | Award | 1,949 | — | Form 4 |
| Jul 10, 2026 | Barlow Jane FDirector | Award | 22,426 | — | Form 4 |
| Jul 10, 2026 | Capone Mark ChristopherDirector | Award | 1,975 | — | Form 4 |
| Jul 10, 2026 | Capone Mark ChristopherDirector | Award | 42,404 | — | Form 4 |
| Jul 10, 2026 | Kamdar Kim P.Director | Award | 3,421 | — | Form 4 |
| Jul 10, 2026 | Kamdar Kim P.Director | Award | 22,426 | — | Form 4 |
| Jul 10, 2026 | Lawrence Sandra AJDirector | Award | 2,276 | — | Form 4 |
| Jul 10, 2026 | Lawrence Sandra AJDirector | Award | 22,426 | — | Form 4 |
| Jul 10, 2026 | Mirza Mansoor RazaDirector | Award | 1,771 | — | Form 4 |
| Jul 10, 2026 | Mirza Mansoor RazaDirector | Award | 22,426 | — | Form 4 |
| Jul 10, 2026 | Phillips JoshuaDirector | Award | 2,260 | — | Form 4 |
| Jul 10, 2026 | Phillips JoshuaDirector | Award | 22,426 | — | Form 4 |
| Jun 11, 2026 | Aerts AustinChief Financial Officer | Sale | 2,037 | $4.09K | Form 4 |
| Jun 11, 2026 | Jackson BenjaminGeneral Counsel | Sale | 2,179 | $4.38K | Form 4 |
| Jun 11, 2026 | Lindgardt ZhenyaChief Executive Officer | Sale | 6,990 | $14.05K | Form 4 |
| Jun 11, 2026 | Inglis Tiffany Eul DavisChief Medical Officer | Sale | 362 | $727.62 | Form 4 |
| Jun 11, 2026 | Anderson Dyaarl Lee Jr.Chief Commercial Officer | Sale | 4,739 | $9.53K | Form 4 |
| Jun 9, 2026 | Aerts AustinChief Financial Officer | Sale | 5,440 | $11.32K | Form 4 |
| Jun 9, 2026 | Lindgardt ZhenyaChief Executive Officer | Sale | 20,755 | $43.17K | Form 4 |
| Jun 8, 2026 | Lawrence Sandra AJDirector | Sale | 1,560 | $3.35K | Form 4 |
| May 29, 2026 | Jackson BenjaminGeneral Counsel | Award | 5,000 | $9.20K | Form 4 |
| May 29, 2026 | Anderson Dyaarl Lee Jr.Chief Commercial Officer | Award | 3,168 | $5.83K | Form 4 |
| Mar 12, 2026 | Inglis Tiffany Eul DavisChief Medical Officer | Award | 17,437 | — | Form 4 |
| Mar 12, 2026 | Aerts AustinChief Financial Officer | Award | 44,215 | — | Form 4 |
| Mar 12, 2026 | Anderson Dyaarl Lee Jr.Chief Commercial Officer | Award | 12,455 | — | Form 4 |
| Mar 12, 2026 | Jackson BenjaminGeneral Counsel | Award | 44,215 | — | Form 4 |
| Mar 12, 2026 | Lindgardt ZhenyaChief Executive Officer | Award | 154,440 | — | Form 4 |
| Mar 11, 2026 | Aerts AustinChief Financial Officer | Sale | 1,019 | $2.08K | Form 4 |
| Mar 11, 2026 | Harrison Robert GardnerChief Information Officer | Sale | 716 | $1.46K | Form 4 |
| Mar 11, 2026 | Boniface John J.Chief Scientific Officer | Sale | 1,517 | $3.09K | Form 4 |
| Mar 11, 2026 | Jackson BenjaminGeneral Counsel | Sale | 1,027 | $2.10K | Form 4 |
| Mar 11, 2026 | Kearney PaulChief Data Officer | Sale | 1,396 | $2.85K | Form 4 |
| Mar 11, 2026 | Lindgardt ZhenyaChief Executive Officer | Sale | 2,973 | $6.06K | Form 4 |
| Mar 10, 2026 | Aerts AustinChief Financial Officer | Sale | 6,069 | $11.53K | Form 4 |
| Mar 10, 2026 | Lindgardt ZhenyaChief Executive Officer | Sale | 22,639 | $43.01K | Form 4 |
| Mar 9, 2026 | Kearney PaulChief Data Officer | Sale | 2,026 | $3.97K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4